Furthermore, Zhang et al. utilized lithium, an FDA-approved GSK3β inhibitor, to suppress GSK3β activity, and found that it reduced the severity of experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, by promoting the function of regulatory T cells [44]. The gene discussed is GSK3B; the disease is experimental autoimmune encephalomyelitis.